Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 25, 2021
Chemopreventive effects of Melastoma malabathricum L. extract in mammary tumor model via inhibition of oxidative stress and inflammatory cytokinesVikas Kumar, Richa Sachan, Mahfoozur Rahman, et al.Oncogene|December 3, 2021
Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancerSultan Alhayyani, Louise McLeod, Alison C West, et al.Current Diabetes Reviews|February 28, 2024
Recent Patterns and Assessment of Long-term Complications followi ngSARS-CoV-2 Infection and Vaccination in the Context of Diabet esPrevalence among Blood DonorsTurki Mohammed M Alqahtani, Mohammed Abdullah Ali Alghamdi, Mirza Rafi Baig, et al.Molecules (Basel, Switzerland)|March 11, 2023
Potential Anticancer Activity of <i>Juniperus procera</i> and Molecular Docking Models of Active Proteins in Cancer CellsSultan Alhayyani, Abdullah Akhdhar, Amer H Asseri, et al.Scientific Reports|May 23, 2023
Identification of novel interacts partners of ADAR1 enzyme mediating the oncogenic process in aggressive breast cancerNajat Binothman, Majidah Aljadani, Bandar Alghanem, et al.ACS Omega|September 15, 2025
FlyTracks and SmellPrints: A Multiscale Forensic Blueprint Linking Necrophagous Insect Behavior, Environmental Decay, and Molecular Affinity for Cadaveric VOCsAhmed S Hashem, Marwa M Ramadan, Osama S Elserafy, et al.American Journal of Respiratory and Critical Care Medicine|July 5, 2016
Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary EmphysemaSaleela M Ruwanpura, Louise McLeod, Lovisa F Dousha, et al.EMBO Molecular Medicine|March 6, 2019
ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancerMohamed I Saad, Sultan Alhayyani, Louise McLeod, et al.Pageof 3